WO2005112952A3 - Geldanamycin compounds and method of use - Google Patents

Geldanamycin compounds and method of use Download PDF

Info

Publication number
WO2005112952A3
WO2005112952A3 PCT/US2005/017966 US2005017966W WO2005112952A3 WO 2005112952 A3 WO2005112952 A3 WO 2005112952A3 US 2005017966 W US2005017966 W US 2005017966W WO 2005112952 A3 WO2005112952 A3 WO 2005112952A3
Authority
WO
WIPO (PCT)
Prior art keywords
geldanamycin compounds
geldanamycin
compounds
inhibiting
disease
Prior art date
Application number
PCT/US2005/017966
Other languages
French (fr)
Other versions
WO2005112952A2 (en
Inventor
Daniel V Santi
Zong-Qiang Tian
Yaoquan Liu
Zhan Wang
Original Assignee
Kosan Biosciences Inc
Daniel V Santi
Zong-Qiang Tian
Yaoquan Liu
Zhan Wang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kosan Biosciences Inc, Daniel V Santi, Zong-Qiang Tian, Yaoquan Liu, Zhan Wang filed Critical Kosan Biosciences Inc
Priority to EP05779991A priority Critical patent/EP1747005A4/en
Priority to CA002563979A priority patent/CA2563979A1/en
Priority to JP2007527525A priority patent/JP2008505984A/en
Publication of WO2005112952A2 publication Critical patent/WO2005112952A2/en
Publication of WO2005112952A3 publication Critical patent/WO2005112952A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom

Abstract

Geldanamycin compounds having a structure according to formula (I) where Q1, L, L1, R5, R6 and R11 are as defined herein, are useful for treating a disease or disorder ameliorated by inhibiting the function of extracellular heat shock protein-90.
PCT/US2005/017966 2004-05-20 2005-05-19 Geldanamycin compounds and method of use WO2005112952A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP05779991A EP1747005A4 (en) 2004-05-20 2005-05-19 Geldanamycin compounds and method of use
CA002563979A CA2563979A1 (en) 2004-05-20 2005-05-19 Geldanamycin compounds and method of use
JP2007527525A JP2008505984A (en) 2004-05-20 2005-05-19 Geldanamycin compounds and methods of use

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US57330604P 2004-05-20 2004-05-20
US60/573,306 2004-05-20
US58451504P 2004-06-30 2004-06-30
US60/584,515 2004-06-30
US11/133,880 US7259156B2 (en) 2004-05-20 2005-05-17 Geldanamycin compounds and method of use
US11/133,880 2005-05-17

Publications (2)

Publication Number Publication Date
WO2005112952A2 WO2005112952A2 (en) 2005-12-01
WO2005112952A3 true WO2005112952A3 (en) 2007-09-27

Family

ID=35426141

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/017966 WO2005112952A2 (en) 2004-05-20 2005-05-19 Geldanamycin compounds and method of use

Country Status (5)

Country Link
US (2) US7259156B2 (en)
EP (1) EP1747005A4 (en)
JP (1) JP2008505984A (en)
CA (1) CA2563979A1 (en)
WO (1) WO2005112952A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100500668C (en) * 2006-12-19 2009-06-17 中国人民解放军军事医学科学院毒物药物研究所 Geldanamycin derivative and its preparing method and use for preparing medicine
US20100113602A1 (en) * 2007-02-27 2010-05-06 The United States Of America,As Represented By The Secretary,Department Of Health And Human Services Use of histone deacetylase inhibitors for the treatment of central nervous system metastases
US20100098690A1 (en) * 2007-03-05 2010-04-22 Kyowa Hakko Kirin Co., Ltd. Pharmaceutical composition
WO2008116216A1 (en) * 2007-03-22 2008-09-25 Medical College Of Georgia Research Institute, Inc. Compositions and methods for inhibiting cancer metastasis
US8426396B2 (en) 2008-01-08 2013-04-23 Shriners Hospitals For Children Treatment for achondroplasia
CN101220068B (en) * 2008-01-18 2012-06-13 中国医学科学院医药生物技术研究所 A set of geldanamycin derivant and method for preparing the same
DE102008060549A1 (en) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Drug-peptide construct for extracellular accumulation
US8945627B2 (en) 2011-05-05 2015-02-03 Wisconsin Alumni Research Foundation Micelles for the solubilization of gossypol
US10682415B2 (en) 2013-07-22 2020-06-16 Wisconsin Alumni Research Foundation Thermogel formulation for combination drug delivery

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6670348B1 (en) * 1997-05-14 2003-12-30 Sloan-Kettering Institute For Cancer Research Methods and compositions for destruction of selected proteins

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US45570A (en) * 1864-12-27 abbeceombie
US26894A (en) * 1860-01-24 Improvement in machinery for laying rope
US53909A (en) * 1866-04-10 Improvement in seeding-machines
US77279A (en) * 1868-04-28 Improvement in potato-diggek
US1114450A (en) * 1914-02-06 1914-10-20 George Edmond Denman Liquid-fuel burner.
JPS55111470A (en) 1979-02-19 1980-08-28 Kaken Pharmaceut Co Ltd Geldanamycin derivative, its preparation, antitumor drug comprising it as active ingredient
US4261989A (en) 1979-02-19 1981-04-14 Kaken Chemical Co. Ltd. Geldanamycin derivatives and antitumor drug
JPS55111419A (en) 1979-02-20 1980-08-28 Kaken Pharmaceut Co Ltd Antitumorigenic agent
JPS63218620A (en) 1987-03-09 1988-09-12 Kyowa Hakko Kogyo Co Ltd Normalizing agent for cancerated cell
JPH0446120A (en) 1990-06-11 1992-02-17 Kyowa Hakko Kogyo Co Ltd Arteralization inhibiting agent
CA2146668A1 (en) 1992-10-14 1994-04-28 Luke Whitesell Tumoricidal activity of benzoquinonoid ansamycins against prostate cancer and primitive neural malignancies
US5932566A (en) 1994-06-16 1999-08-03 Pfizer Inc. Ansamycin derivatives as antioncogene and anticancer agents
US5662883A (en) 1995-01-10 1997-09-02 Nanosystems L.L.C. Microprecipitation of micro-nanoparticulate pharmaceutical agents
US5534270A (en) 1995-02-09 1996-07-09 Nanosystems Llc Method of preparing stable drug nanoparticles
US5510118A (en) 1995-02-14 1996-04-23 Nanosystems Llc Process for preparing therapeutic compositions containing nanoparticles
WO1996034525A1 (en) 1995-05-02 1996-11-07 The Regents Of The University Of California Inducement of thermotolerance with benzoquinonoid ansamycins
WO2000003737A2 (en) 1998-07-17 2000-01-27 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Water-soluble drugs and methods for their production
US6174875B1 (en) 1999-04-01 2001-01-16 University Of Pittsburgh Benzoquinoid ansamycins for the treatment of cardiac arrest and stroke
AU769235B2 (en) 1999-04-09 2004-01-22 Sloan-Kettering Institute For Cancer Research Methods and compositions for degradation and/or inhibition of her-family tyrosine kinases
EP1466627A1 (en) 1999-10-12 2004-10-13 Cell Therapeutics, Inc. Polyglutamate camptothecin conjugates
WO2002036574A1 (en) 2000-11-06 2002-05-10 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Geldanamycin derivatives useful for the treatment of cancer
ES2268068T3 (en) 2001-03-30 2007-03-16 The Usa, Represented By The Secretary, Dept. Of Health And Human Services National Institutes Health DERIVED FROM GELDANAMYCIN USEFUL FOR THE TREATMENT OF CANCER.
WO2003013430A2 (en) * 2001-08-06 2003-02-20 Kosan Biosciences, Inc. Benzoquinone ansamycins
US6872715B2 (en) 2001-08-06 2005-03-29 Kosan Biosciences, Inc. Benzoquinone ansamycins
CA2468202A1 (en) * 2001-12-12 2003-06-19 Conforma Therapeutics Corporation Assays and implements for determining and modulating hsp90 binding activity
ATE433961T1 (en) 2002-02-08 2009-07-15 Conforma Therapeutics Corp ANSAMYCINS WITH IMPROVED PHARMACOLOGICAL AND BIOLOGICAL PROPERTIES
US7241754B2 (en) 2003-06-13 2007-07-10 Kosan Biosciences, Inc. 2-Desmethyl ansamycin compounds
US6875863B1 (en) 2003-11-12 2005-04-05 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US6887993B1 (en) 2003-11-12 2005-05-03 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US6855705B1 (en) 2003-11-12 2005-02-15 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
CA2545457A1 (en) 2003-11-12 2005-06-23 Kosan Biosciences, Inc. 11-o-methylgeldanamycin compounds
EP1737825A1 (en) * 2004-03-26 2007-01-03 Van Andel Research Institute Geldanamycin and derivatives inhibit cancer invasion and identify novel targets

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6670348B1 (en) * 1997-05-14 2003-12-30 Sloan-Kettering Institute For Cancer Research Methods and compositions for destruction of selected proteins

Also Published As

Publication number Publication date
CA2563979A1 (en) 2005-12-01
JP2008505984A (en) 2008-02-28
EP1747005A4 (en) 2011-06-15
EP1747005A2 (en) 2007-01-31
US7378407B2 (en) 2008-05-27
US20050267046A1 (en) 2005-12-01
US20070270396A1 (en) 2007-11-22
US7259156B2 (en) 2007-08-21
WO2005112952A2 (en) 2005-12-01

Similar Documents

Publication Publication Date Title
WO2005112952A3 (en) Geldanamycin compounds and method of use
GB0510143D0 (en) Novel compounds A1
EP1740581A4 (en) 2, 4, 6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
ZA200802163B (en) 5-(phenylisoxazolylethoxy)-triazol-3-YL substituted pyridine compounds for the treatment of neurological, psychiatric or pain disorders
IN2014DN08588A (en)
TNSN08269A1 (en) Derives de pyrimidine
PH12014502420B1 (en) Iap bir domain binding compound
TW200745138A (en) Process for stabilising thiophene derivatives
UA92355C2 (en) urn:schemas-microsoft-com:office:smarttags2,4-DIAMINO-PYRIMIDINES USED AS AURORAINHIBITORS
EP1740559A4 (en) 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
WO2009051670A3 (en) Oxylipin compounds for the treatment of ophthalmic conditions
WO2005087771A3 (en) 5,6-dialkyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds
IL191629A0 (en) Tricyclic amide derivatives useful for treating obesity
EP1817311A4 (en) 2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
WO2005087700A3 (en) Bisphenyl compounds useful as vitamin d3 receptor agonists
EP1705251A4 (en) PROCESS FOR PRODUCING ANTIBODY COMPOSITION BY USING RNA INHIBITING THE FUNCTION OF a1,6-FUCOSYLTRANSFERASE
WO2003093269A3 (en) Substituted pyrazolo-pyrimidine-4-ones
WO2006133391A3 (en) Improved treatment for anemia using a hif-alpha stabilising agent
WO2008001195A3 (en) Novel processes for the preparation of dpp iv inhibitors
WO2008040649A3 (en) Pyrazine-2-carboxamide derivatives as cb2 receptor modulators
TW200621739A (en) Asymmetric synthesis of substituted dihydrobenzofurans
MX2009006444A (en) Method for producing c-glycoside derivative and synthetic intermediate thereof.
WO2009018065A3 (en) Novel glucokinase activators and methods of using same
WO2008146914A1 (en) Heterocyclic compound
WO2008045371A3 (en) N-substituted-azacyclylamines as histamine-3 antagonists

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2563979

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2007527525

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWE Wipo information: entry into national phase

Ref document number: 2005779991

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2005779991

Country of ref document: EP